CARL · Carlsmed, Inc. · Exempt Offerings
$14.99
-0.79 (-4.98%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$430.56M
Shares
27.30M
Volume · Oct 30
42.27K
Avg daily vol (3M)
111.94K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-02-07 | Amendment | Other | $64,499,995 | $64,499,995 | 06b |
| 2024-03-21 | New | Other | $52,499,996 | $38,499,996 | 06b |
| 2022-04-27 | New | Biotechnology | $29,999,990 | $29,999,990 | 06b |
| 2020-12-17 | New | Biotechnology | $12,643,855 | $12,634,480 | 06b |
| 2020-05-15 | Amendment | Biotechnology | $2,485,000 | $1,985,000 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1794546
CUSIP
14280C105
13F (30d)
13 filings
13 filers
Visit website
Investor relations